Review of: “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949

Detalles Bibliográficos
Autor principal: Rosendaal, Frits R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author. Published by Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357515/
https://www.ncbi.nlm.nih.gov/pubmed/32674928
http://dx.doi.org/10.1016/j.ijantimicag.2020.106063
_version_ 1783558696488402944
author Rosendaal, Frits R.
author_facet Rosendaal, Frits R.
author_sort Rosendaal, Frits R.
collection PubMed
description
format Online
Article
Text
id pubmed-7357515
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Author. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-73575152020-07-13 Review of: “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949 Rosendaal, Frits R. Int J Antimicrob Agents Article The Author. Published by Elsevier B.V. 2020-07 2020-07-13 /pmc/articles/PMC7357515/ /pubmed/32674928 http://dx.doi.org/10.1016/j.ijantimicag.2020.106063 Text en © 2020 The Author. Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Rosendaal, Frits R.
Review of: “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949
title Review of: “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949
title_full Review of: “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949
title_fullStr Review of: “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949
title_full_unstemmed Review of: “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949
title_short Review of: “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949
title_sort review of: “hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial gautret et al 2010, doi:10.1016/j.ijantimicag.2020.105949
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357515/
https://www.ncbi.nlm.nih.gov/pubmed/32674928
http://dx.doi.org/10.1016/j.ijantimicag.2020.106063
work_keys_str_mv AT rosendaalfritsr reviewofhydroxychloroquineandazithromycinasatreatmentofcovid19resultsofanopenlabelnonrandomizedclinicaltrialgautretetal2010doi101016jijantimicag2020105949

Ejemplares similares